2022-RA-1112-ESGO MFAP5 is related to ovarian cancer progression but not suitable as prognostic biomarker | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Ovarian cancer

2022-RA-1112-ESGO MFAP5 is related to ovarian cancer progression but not suitable as prognostic biomarker

Free

Online download statistics by month:

Online download statistics by month: October 2022 to October 2024

	Abstract	Full	Pdf
Oct 2022	10	0	1
Nov 2022	19	0	2
Dec 2022	48	0	11
Jan 2023	21	0	5
Feb 2023	6	0	1
Mar 2023	4	0	0
Apr 2023	14	0	0
May 2023	11	0	1
Jun 2023	2	0	0
Jul 2023	25	0	4
Aug 2023	5	0	3
Sep 2023	10	0	2
Oct 2023	10	0	0
Nov 2023	20	0	4
Dec 2023	9	0	1
Jan 2024	19	0	1
Feb 2024	9	0	1
Mar 2024	18	0	5
Apr 2024	15	0	4
May 2024	30	0	4
Jun 2024	6	0	2
Jul 2024	6	0	3
Aug 2024	10	0	5
Sep 2024	22	0	1
Oct 2024	2	0	0
Total	351	0	61